CHAMPIONS ONCOLOGY, ...
Display and export data
General & Ratios
Financial Statements
/
In the 'original' view, the statements are displayed just as they are being reported by the company.
In the 'standardised' view, the statements are displayed in a standardised format (line items are identical for all companies).
Add data
Click on one of the orange fields in the profile to add new information
Edit or review data
Legend (for Financial Statements)
Passed value check (?)
Failed value check (?)
Click on a coloured field in the profile to review the data
Close sidebar
Loading: 100%
CHAMPIONS ONCOLOGY, INC. logo
no logo available
General Information
Investor relations pageIR page no data available
Founding year no data available
Headquarter , , no data available
Employees 79 (as per Q2 2017)no data available
Sector Biotechnology, HealthcareBiotechnology, Healthcareno data available
Ticker CSBRno data available
Financial year endsFY ends End of Aprilno data available
Stock Information (historical prices adjusted for splits and dividends)
Adj. Closing prices (in USD) -Common sharesNov. 16Jan. 17März 17Mai 17Juli 17Sep. 170,01,53,04,56,0
datesClosing price (adj.)
13.10.20173.41
11.10.20173.28
04.10.20173.48
27.09.20173.97
20.09.20173.49
13.09.20173.40
06.09.20173.10
30.08.20173.09
23.08.20173.12
16.08.20173.09
09.08.20173.15
02.08.20172.93
26.07.20172.57
19.07.20172.66
12.07.20172.54
05.07.20172.70
27.06.20172.88
20.06.20172.53
13.06.20172.49
06.06.20172.36
30.05.20172.45
23.05.20172.46
16.05.20172.43
09.05.20172.42
02.05.20172.68
25.04.20172.86
18.04.20172.86
11.04.20172.85
04.04.20173.01
28.03.20173.18
21.03.20172.99
14.03.20173.03
07.03.20173.06
28.02.20173.45
21.02.20173.30
14.02.20173.66
07.02.20174.17
31.01.20174.75
24.01.20173.65
17.01.20173.61
10.01.20173.51
03.01.20172.85
27.12.20162.51
19.12.20162.55
12.12.20162.32
05.12.20162.28
28.11.20161.90
21.11.20161.81
14.11.20161.94
07.11.20161.63
31.10.20161.58
24.10.20161.63
17.10.20161.68
no share price data source found
Share price data requested
Key Figures
Last Closing Price
as per Oct 13, 2017, in USD
 3.41n/a
Market Capitalisation
in million USD
 37n/a
Enterprise Value
in million USD
 33n/a
Common Shares Outstanding
as per Oct 31, 2016
 10,967,491n/a
Preferred Shares Outstanding
as per Oct 31, 2016
 n/a
Average Basic Shares Outstanding
TTM
 8,695,199n/a
Average Diluted Shares Outstanding
TTM
 9,124,125n/a
Index Membership
n/a
Business Summary
Champions Oncology Inc is engaged in the development and sale of technology solutions and products to personalize the development and use of oncology drugs.
no data available
Key Financials & Ratios (all figures TTM as per Jul 31, 2016, million USD, full statements further below)
Profit & Loss
Revenues 12n/a
Gross Profit 3n/a
Operating Income -10n/a
EBITDA 0n/a
Net Profit -10n/a
Balance Sheet
Cash and Cash Equivalents 5n/a
Receivables 2n/a
Total Current Assets 6n/a
PP&E 1n/a
Total Assets 8n/a
Accounts Payable 2n/a
Current Debt 0n/a
Total Current Liabilities 4n/a
Long-Term Debt 0n/a
Total Liabilities 5n/a
Total Equity 3n/a
Cash Flow
Depreciation & Amortisation 0n/a
Change in Working Capital 0n/a
Operating Cash Flow 0n/a
Net Change in PP&E and Intangibles 0n/a
Investing Cash Flow 0n/a
Dividends Paid 0n/a
Financing Cash Flow 0n/a
Total Change in Cash 0n/a
Free Cash Flow 0n/a
Profitability Ratios
Gross Margin 25.3%n/a
Operating Margin -82.6%n/a
Net Profit Margin -83.8%n/a
Return on Equity -317.4%n/a
Return on Assets -127.8%n/a
Per Share Figures
Basic EPS n/a
Diluted EPS n/a
Sales per Share n/a
Book Value per Share n/a
FCF per Share n/a
Dividends per Share n/a
Price Multiples
Price to Earnings Ratio n/a
Price to Sales Ratio n/a
Price to Book Value n/a
Price to Free Cash Flow n/a
Valuation Metrics
EV/EBITDA n/a
EV/Sales 2.73n/a
Book to Market Value 0.08n/a
Other Ratios
Current Ratio 146.3%n/a
Liabilities to Equity Ratio 147.1%n/a
Debt to Assets Ratio 0.0%n/a
Profit & Loss StatementP&L data quality: 5% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15FY '16
Revenue
7
7
8
12
9
11
Sales & Services Revenue
0
0
0
0
0
0
Financing Revenue
0
0
0
0
0
0
Other Revenue
0
0
0
0
0
0
Cost of revenue
-4
-5
-5
-6
-8
-9
Cost of Goods & Services
0
0
0
0
0
0
Cost of Financing Revenue
0
0
0
0
0
0
Cost of Other Revenue
0
0
0
0
0
0
Gross Profit
3
2
3
5
1
2
Other Operating Income
0
0
0
0
0
0
Operating Expenses
-9
-11
-9
-12
-14
-13
Selling, General & Administrative
-6
-8
-7
-9
-10
-9
Selling & Marketing
0
0
0
0
0
0
General & Administrative
0
0
0
0
0
0
Research & Development
-3
-3
-2
-2
-5
-4
Depreciation & Amortization
0
0
0
0
0
0
Provision For Doubtful Accounts
0
0
0
0
0
0
Other Operating Expense
0
0
0
0
0
0
Operating Income (Loss)
-5
-9
-6
-6
-13
-10
Non-Operating Income (Loss)
0
0
0
0
0
0
Interest Expense, net
0
0
0
0
0
0
Interest Expense
0
0
0
0
0
0
Interest Income
0
0
0
0
0
0
Other Investment Income (Loss)
0
0
0
0
0
0
Foreign Exchange Gain (Loss)
0
0
0
0
0
0
Income (Loss) from Affiliates
0
0
0
0
0
0
Other Non-Operating Income (Loss)
0
0
0
0
0
0
Pretax Income (Loss), Adjusted
-5
-9
-6
-6
-13
-10
Abnormal Gains (Losses)
-1
0
0
1
0
0
Acquired In-Process R&D
0
0
0
0
0
0
Merger / Acquisition Expense
0
0
0
0
0
0
Abnormal Derivatives
0
0
0
0
0
0
Disposal of Assets
0
0
0
0
0
0
Early extinguishment of Debt
0
0
0
0
0
0
Asset Write-Down
0
0
0
0
0
0
Impairment of Goodwill & Intangibles
0
0
0
0
0
0
Sale of Business
0
0
0
0
0
0
Legal Settlement
0
0
0
0
0
0
Restructuring Charges
0
0
0
0
0
0
Sale of and Unrealized Investments
0
0
0
0
0
0
Insurance Settlement
0
0
0
0
0
0
Other Abnormal Items
0
0
0
0
0
0
Pretax Income (Loss)
-7
-9
-6
-5
-14
-10
Income Tax (Expense) Benefit, net
0
0
0
0
0
0
Current Income Tax
0
0
0
0
0
0
Deferred Income Tax
0
0
0
0
0
0
Tax Allowance/Credit
0
0
0
0
0
0
Income (Loss) from Affiliates, net of taxes
0
0
0
0
0
0
Income (Loss) from Continuing Operations
-7
-9
-6
-5
-14
-10
Net Extraordinary Gains (Losses)
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
XO & Accounting Charges & Other
0
0
0
0
0
0
Income (Loss) Including Minority Interest
-7
-9
-6
-5
-14
-10
Minority Interest
0
0
0
0
0
0
Net Income
-7
-9
-6
-5
-14
-10
Preferred Dividends
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
Net Income Available to Common Shareholders
-7
-9
-6
-5
-14
-10
Remarks
restated on Jul 18, 2012 n/a
calculated values,
restated on Jul 26, 2013 n/a
calculated values,
restated on Jul 28, 2014 n/a
calculated values,
restated on Jul 29, 2015 n/a
calculated values,
restated on Jul 29, 2016 n/a
calculated values,
restated on Jul 29, 2016 n/a
calculated values,
Balance SheetBS data quality: 98% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15FY '16
Assets
Cash, Cash Equivalents & Short Term Investments
10
5
10
6
9
3
Cash & Cash Equivalents
10
5
10
6
9
3
Short Term Investments
0
0
0
0
0
0
Accounts & Notes Receivable
1
1
1
1
1
1
Accounts Receivable, Net
1
1
1
1
1
1
Notes Receivable, Net
0
0
0
0
0
0
Unbilled Revenues
0
0
0
0
0
0
Inventories
0
0
0
0
0
0
Raw Materials
0
0
0
0
0
0
Work In Process
0
0
0
0
0
0
Finished Goods
0
0
0
0
0
0
Other Inventory
0
0
0
0
0
0
Other Short Term Assets
1
0
0
0
0
0
Prepaid Expenses
0
0
0
0
0
0
Derivative & Hedging Assets
0
0
0
0
0
0
Assets Held-for-Sale
0
0
0
0
0
0
Deferred Tax Assets
0
0
0
0
0
0
Income Taxes Receivable
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
Miscellaneous Short Term Assets
1
0
0
0
0
0
Total Current Assets
12
6
10
8
11
4
Property, Plant & Equipment, Net
0
1
0
0
0
1
Property, Plant & Equipment
0
0
0
0
0
0
Accumulated Depreciation
0
0
0
0
0
0
Long Term Investments & Receivables
0
0
0
0
0
0
Long Term Investments
0
0
0
0
0
0
Long Term Marketable Securities
0
0
0
0
0
0
Long Term Receivables
0
0
0
0
0
0
Other Long Term Assets
1
1
1
1
1
1
Intangible Assets
0
0
0
0
0
0
Goodwill
1
1
1
1
1
1
Other Intangible Assets
0
0
0
0
0
0
Prepaid Expense
0
0
0
0
0
0
Deferred Tax Assets
0
0
0
0
0
0
Derivative & Hedging Assets
0
0
0
0
0
0
Prepaid Pension Costs
0
0
0
0
0
0
Discontinued Operations
0
0
0
0
0
0
Investments in Affiliates
0
0
0
0
0
0
Miscellaneous Long Term Assets
0
0
0
0
0
0
Total Noncurrent Assets
1
1
1
1
1
1
Total Assets
13
7
12
9
12
6
Liabilities and owners' equity
Payables & Accruals
2 1882000
2 2301000
2 1815000
2 1568000
2 1787000
2 2167000
Accounts Payable
2 1580000
2 1676000
1 1204000
1 981000
1 1414000
2 1896000
Accrued Taxes
0 0
0 0
0 0
0 0
0 0
0 0
Interest & Dividends Payable
0 0
0 0
0 0
0 0
0 0
0 0
Other Payables & Accruals
0 302000
1 625000
1 611000
1 587000
0 373000
0 271000
Short Term Debt
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Borrowings
0 0
0 0
0 0
0 0
0 0
0 0
Short Term Capital Leases
0 0
0 0
0 0
0 0
0 0
0 0
Current Portion of Long Term Debt
0 0
0 0
0 0
0 0
0 0
0 0
Other Short Term Liabilities
2 1618000
1 1185000
1 1114000
2 2091000
2 2009000
3 3139000
Deferred Revenue
2 1618000
1 1185000
1 1114000
2 2091000
2 2009000
3 3139000
Derivatives & Hedging
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
0 0
0 0
0 0
0 0
0 0
0 0
Discontinued Operations
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Short Term Liabilities
0 0
0 0
0 0
0 0
0 0
0 0
Total Current Liabilities
4 3500000
3 3486000
3 2929000
4 3659000
4 3796000
5 5306000
Long Term Debt
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Borrowings
0 0
0 0
0 0
0 0
0 0
0 0
Long Term Capital Leases
0 0
0 0
0 0
0 0
0 0
0 0
Other Long Term Liabilities
1 972000
1 555000
1 1046000
2 2011000
0 192000
0 233000
Accrued Liabilities
0 0
0 0
0 0
0 0
0 0
0 0
Pension Liabilities
0 0
0 0
0 0
0 0
0 0
0 0
Pensions
0 0
0 0
0 0
0 0
0 0
0 0
Other Post-Retirement Benefits
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Compensation
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Revenue
0 0
0 0
0 0
0 0
0 0
0 0
Deferred Tax Liabilities
0 0
0 0
0 0
0 0
0 0
0 0
Derivatives & Hedging
1 972000
1 555000
1 1046000
2 2011000
0 0
0 0
Discontinued Operations
0 0
0 0
0 0
0 0
0 0
0 0
Miscellaneous Long Term Liabilities
0 0
0 0
0 0
0 0
0 192000
0 233000
Total Noncurrent Liabilities
1 972000
1 555000
1 1046000
2 2011000
0 192000
0 233000
Total Liabilities
4 4472000
4 4041000
4 3975000
6 5670000
4 3988000
6 5539000
Preferred Equity
0 0
0 0
0 0
0 0
0 0
0 0
Share Capital & Additional Paid-In Capital
18 17821000
21 21242000
24 23619000
43 43329000
61 61331000
64 63956000
Common Stock
0 0
0 0
0 0
0 0
0 0
0 0
Additional Paid in Capital
0 0
0 0
0 0
0 0
0 0
0 0
Other Share Capital
0 0
0 0
0 0
0 0
0 0
0 0
Treasury Stock
-1 -1252000
-1 -1252000
-1 -1252000
-1 -1252000
-1 -1252000
-1 -1252000
Retained Earnings
-16 -16482000
-25 -25143000
-31 -31473000
-39 -38880000
-52 -52020000
-62 -62466000
Other Equity
0 -68000
0 -125000
0 -100000
0 0
0 0
0 0
Equity Before Minority Interest
0 19000
-5 -5278000
-9 -9206000
3 3197000
8 8059000
0 238000
Minority Interest
8 8159000
8 8159000
17 16882000
0 0
0 0
0 0
Total Equity
8 8178000
3 2881000
8 7676000
3 3197000
8 8059000
0 238000
Total Liabilities & Equity
13 12650000
7 6922000
12 11651000
9 8867000
12 12047000
6 5777000
Remarks restated on Jul 18, 2012 n/a restated on Jul 26, 2013 n/a restated on Jul 28, 2014 n/a restated on Jul 29, 2015 n/a restated on Jul 29, 2016 n/a restated on Dec 14, 2016 n/a
Cash Flow StatementCF data quality: 92% (?)
edit
No data available yet
Loading data...
No data available for the original financial statements for the selected time periods. You can change the selected time periods by clicking on 'data' on the top right.
Standardised statements can't be displayed.
Reason:
No data available for the selected time periods
in million USD FY '11FY '12FY '13FY '14FY '15FY '16
Net Income/Starting Line
-4
-9
-6
-7
-13
-10
Net Income
0
0
0
0
0
0
Net Income From Discontinued Operations
0
0
0
0
0
0
Other Adjustments
0
0
0
0
0
0
Depreciation & Amortization
0
0
0
0
0
0
Non-Cash Items
3
3
2
4
3
3
Stock-Based Compensation
0
0
0
0
0
0
Deferred Income Taxes
0
0
0
0
0
0
Other Non-Cash Adjustments
0
0
0
0
0
0
Change in Working Capital
1
1
-1
0
1
1
(Increase) Decrease in Accounts Receivable
0
0
0
0
0
0
(Increase) Decrease in Inventories
0
0
0
0
0
0
Increase (Decrease) in Accounts Payable
0
0
0
0
0
0
Increase (Decrease) in Other
0
0
0
0
0
0
Net Cash From Discontinued Operations (operating)
0
0
0
0
0
0
Cash from Operating Activities
0
-5
-4
-3
-10
-6
Change in Fixed Assets & Intangibles
0
-1
0
0
0
0
Disposition of Fixed Assets & Intangibles
0
0
0
0
0
0
Disposition of Fixed Assets
0
0
0
0
0
0
Disposition of Intangible Assets
0
0
0
0
0
0
Acquisition of Fixed Assets & Intangibles
0
0
0
0
0
0
Purchase of Fixed Assets
0
0
0
0
0
0
Acquisition of Intangible Assets
0
0
0
0
0
0
Other Change in Fixed Assets & Intangibles
0
0
0
0
0
0
Net Change in Long Term Investment
0
0
0
0
0
0
Decrease in Long Term Investment
0
0
0
0
0
0
Increase in Long Term Investment
0
0
0
0
0
0
Net Cash From Acquisitions & Divestitures
0
0
0
0
0
0
Net Cash from Divestitures
0
0
0
0
0
0
Cash for Acqusition of Subsidiaries
0
0
0
0
0
0
Cash for Joint Ventures
0
0
0
0
0
0
Net Cash from Other Acquisitions
0
0
0
0
0
0
Other Investing Activities
0
0
0
0
0
0
Net Cash From Discontinued Operations (investing)
0
0
0
0
0
0
Cash from Investing Activities
0
-1
0
0
0
0
Dividends Paid
0
0
0
0
0
0
Cash From (Repayment of) Debt
9
0
9
0
13
0
Cash From (Repayment of) Short Term Debt, net
0
0
0
0
0
0
Cash From (Repayment of) Long Term Debt, net
0
0
0
0
0
0
Repayments of Long Term Debt
0
0
0
0
0
0
Cash From Long Term Debt
0
0
0
0
0
0
Cash From (Repurchase of) Equity
-1
0
0
0
0
0
Increase in Capital Stock
0
0
0
0
0
0
Decrease in Capital Stock
-1
0
0
0
0
0
Other Financing Activities
0
0
0
0
0
0
Net Cash From Discontinued Operations (financing)
0
0
0
0
0
0
Cash from Financing Activities
8
0
9
0
13
0
Net Cash Before Disc. Operations and FX
8
-6
5
-4
3
-7
Change in Cash from Disc. Operations and Other
0
0
0
0
0
0
Net Cash Before FX
8
-6
5
-4
3
-7
Effect of Foreign Exchange Rates
0
0
0
0
0
0
Net Changes in Cash
8
-6
5
-4
3
-7
Remarks
restated on Jul 18, 2012 n/a
calculated values,
restated on Jul 26, 2013 n/a
calculated values,
restated on Jul 28, 2014 n/a
calculated values,
restated on Jul 29, 2015 n/a
calculated values,
restated on Jul 29, 2016 n/a
calculated values,
restated on Jul 29, 2016 n/a
calculated values,
Some of the data shown on this page is provided for free by IEX
About | Contact Forum | Legal
SimFin UG 2017 - Beta v. 1.42
Facebook | Twitter | Medium
Sumo